v3.26.1
Segment Reporting - Schedule of Segment Information (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Schedule of Segment Information [Line Items]      
Net revenues $ 596,817 $ 510,360 $ 350,131
Cost of revenues (429,407) (355,004) (196,686)
Gross profit 167,410 155,356 153,445
Total operating expenses (5,439,131) (1,617,286) (163,292)
Operating loss (5,271,721) (1,461,930) (9,847)
Finance income, net 80,162 11,036  
Other income (expenses), net 46,803 64,415 29,351
Change in fair value of warrant liabilities (3,168,091)
Income tax expenses 1,531 (25,080) (4,090)
Net income loss (8,311,316) (1,411,559) $ 13,560
Identifiable long-lived assets 2,677,549 2,768,112  
Total assets 13,779,397 6,864,226  
Sales of medical and other related products [Member]      
Schedule of Segment Information [Line Items]      
Net revenues 561,817 510,360  
Cost of revenues (401,264) (355,004)  
Gross profit 160,553 155,356  
Total operating expenses (444,208) (447,642)  
Operating loss (283,655) (292,286)  
Finance income, net 18,397 10,068  
Other income (expenses), net 46,942 64,444  
Change in fair value of warrant liabilities    
Income tax expenses 1,531 (25,080)  
Net income loss (216,785) (242,854)  
Identifiable long-lived assets 67,810 88,077  
Total assets 2,337,152 2,219,996  
Research and development of pancreatic cancer early detection services [Member]      
Schedule of Segment Information [Line Items]      
Net revenues  
Cost of revenues  
Gross profit  
Total operating expenses (143,927) (53,678)  
Operating loss (143,927) (53,678)  
Finance income, net  
Other income (expenses), net  
Change in fair value of warrant liabilities    
Income tax expenses  
Net income loss (143,927) (53,678)  
Identifiable long-lived assets 1,722,600 1,769,000  
Total assets 1,722,600 1,769,000  
Research and development of sales of contact lenses [Member]      
Schedule of Segment Information [Line Items]      
Net revenues 35,000  
Cost of revenues (28,143)  
Gross profit 6,857  
Total operating expenses (1,805,720) (469,158)  
Operating loss (1,798,863) (469,158)  
Finance income, net  
Other income (expenses), net  
Change in fair value of warrant liabilities    
Income tax expenses  
Net income loss (1,798,863) (469,158)  
Identifiable long-lived assets 887,139 911,035  
Total assets 887,139 911,035  
Corporate unallocated [Member]      
Schedule of Segment Information [Line Items]      
Net revenues  
Cost of revenues  
Gross profit  
Total operating expenses (3,045,276) (646,808)  
Operating loss (3,045,276) (646,808)  
Finance income, net 61,765 968  
Other income (expenses), net (139) (29)  
Change in fair value of warrant liabilities (3,168,091)    
Income tax expenses  
Net income loss (6,151,741) (645,869)  
Identifiable long-lived assets  
Total assets $ 8,832,506 $ 1,964,195